Concord Biotech

Concord Biotech Limited is an R&D-based, vertically integrated biotechnology company that operates state-of-the-art manufacturing facilities. The company specialises in offering fermentation and semi-synthetic Active Pharmaceutical Ingredients (APIs) as well as finished dosage forms. Since its founding in 2000, Concord Biotech has expanded significantly to become a broad-spectrum solution provider, delivering products across a variety of therapeutic segments. The company adheres to current Good Manufacturing Practices (cGMP), with its facilities inspected by global regulatory agencies such as the USFDA, EU-GMP, Japanese AFM, Local FDA, and Korean FDA. Concord Biotech boasts over 20 dedicated API manufacturing blocks and more than 500 KL fermentation capacity, complemented by a separate manufacturing unit for finished dosage forms.

Services include:
- Active Pharmaceutical Ingredients (APIs)
- Finished Dosage Formulation
- Contract Manufacturing Organisation (CMO)
- Contract Development and Manufacturing Organisation (CDMO)
- Contract Research Organisation (CRO)
- Packaging

Concord Biotech is committed to delivering high-quality, complex, and differentiated APIs and formulations, ensuring compliance with international quality standards. For more information, please visit concordbiotech.com.